Feeds:
Posts
Comments

Search Results for 'CRISPR'


On June 12, 2018 – Berkeley was granted a patent on using CRISPR/Cas9 to edit single-stranded RNA. On June 19, 2018 – Berkeley was granted a second patent, covering the use of CRISPR-Cas9 gene editing with formats that will be particularly useful in developing human therapeutics and improvements in food security. Reporter and Curator: Aviva Lev-Ari, PhD, RN […]

Read Full Post »


Reporter and Curator: Dr. Sudipta Saha, Ph.D.   The CRISPR-Cas9 system has proven to be a powerful tool for genome editing allowing for the precise modification of specific DNA sequences within a cell. Many efforts are currently underway to use the CRISPR-Cas9 system for the therapeutic correction of human genetic diseases. CRISPR/Cas9 has revolutionized our […]

Read Full Post »


CRISPR on TED Ideas worth spreading – Ellen Jorgensen Reporter: Aviva Lev-Ari, PhD, RN On same webpage see other CRISPR Talk on TED on the right hand side of the webpage   SOURCE

Read Full Post »


CRISPR snips a strand of DNA – Visualization of the Process Reporter: Aviva Lev-Ari, PhD, RN   Watch what it actually looks like when CRISPR snips a strand of DNA Posted Jan 31, 2018 by Devin Coldewey WATCH VIDEO Molecular animations are an essential way to demystify and explain complex biological systems. Through the use of stunning imagery and attention to detail, […]

Read Full Post »


Developments in CRISPR Patent Dispute: EPO Revokes Broad’s CRISPR Patent Curator: Aviva Lev-Ari, PhD, RN   UPDATED on 1/17/2020 On Thursday, [1/16/2020] the EPO appeals board indicated that it planned to refer the issue to an Enlarged Board of Appeals to decide three questions: whether a European patent application can be refused if it claims the […]

Read Full Post »


CRISPR Based Research Awarded NHGRI Grants, The University of California, Berkeley’s Doudna will receive $2.1 million and The Broad Institute’s Zhang will receive $1.1 million Reporter: Aviva Lev-Ari, PhD, RN   UPDATED on 10/10/2017 Gene Editing Market: CRISPR/CAS9 to be the fastest-growing technology segment – 2024 Request for Sample Copy of this Report @ http://bit.ly/2wExTM9 Rising […]

Read Full Post »


Appellate Brief Seeking Reversal of U.S. Patent Board Decision on CRISPR/Cas9 Gene Editing Reporter: Aviva Lev-Ari, PhD, RN [Boldface added] Appeal seeks reversal of Patent Trial and Appeal Board decision terminating interference without determining priority of inventorship of CRISPR/Cas9 gene editing Brief asserts that the Board failed to properly apply controlling U.S. Supreme Court and […]

Read Full Post »


Innovations on the CRISPR System for Gene Editing: (1) Cryo-electron microscopy-based visualization of Cas3 Enzyme Cleavage (2) New tool testing an entire genome against a CRISPR molecule to predict potential errors and interactions Curator and Reporter: Aviva Lev-Ari, PhD, RN   Boom in human gene editing as 20 CRISPR trials gear up A pioneering CRISPR […]

Read Full Post »


Doudna and Charpentierand their teams to receive wide-ranging patents in many countries:  European Patent Office (EPO) and UK Intellectual Property Office – broad patent for CRISPR-Cas9 gene-editing technology to the University of California and the University of Vienna Reporter: Aviva Lev-Ari, PhD, RN   The EPO patent will cover the single-guide CRISPR-Cas9 technology in cells of […]

Read Full Post »


UPDATED – Gene Editing Consortium of Biotech Companies: CRISPR Therapeutics $CRSP, Intellia Therapeutics $NTLA, Caribou Biosciences, ERS Genomics, UC, Berkeley (Doudna’s IP) and University of Vienna (Charpentier’s IP), is appealing the decision ruled that there was no interference between the two sides, to the U.S. Court of Appeals for the Federal Circuit, targeting patents from The […]

Read Full Post »

« Prev - Next »